Most Recent Articles by Diana Ernst, RPh
This fixed-dose combination product combines lesinurad, a uric acid transporter 1 (URAT1) inhibitor, with allopurinol, a xanthine oxidase inhibitor in one tablet.
Specifically, this panel of independent experts will discuss the the benefits and risk associated with the use of these products in this patient population as well as current treatment practices.
Tanzeum, a glucagon-like peptide-1 (GLP-1) receptor agonst, is indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes.
Premenstrual exacerbation (PME) of depression has been found to occur in roughly two-thirds of women with depressive disorders.
The approvals were based on two, placebo-controlled trials (SOLO-2, Study 19) in patients with recurrent ovarian cancers who were in response to platinum-based therapy.